中西医结合治疗慢性乙型肝炎48例疗效观察
Clinic Study on Treatment of Chronic Hepatitis B with Combination of Chinese and Western medicine in 48 cases
-
摘要: 为了观察中西药物乙型肝炎疫苗、聚肌胞、猪苓多糖及解瘀通络肝炎口服液联合应用对慢性乙型肝炎的疗效。治疗组 48例使用乙型肝炎疫苗、聚肌胞、猪苓多糖及中药解瘀通络肝炎口服液和一般保肝药物 ,对照组 30例仅使用一般性保肝药物 ,共 3个月为 1个疗程。结果治疗组HBsAg、HBeAg和HBVDNA的阴转率分别为 8.33% ,75 %和 79.2 % ,与对照组比较 ,后二者具有明显性差异。治疗组HBsAb和HBeAb阳转率分别为 2 0 .8%和 43.8% ,与对照组比较均具有显著差异。说明中西药物乙型肝炎疫苗、聚肌胞、猪苓多糖及解瘀通络肝炎口服液联合使用治疗慢性乙型肝炎疗效较好 ,且副作用小。
-
关键词:
- 乙型肝炎疫苗 /
- 聚肌胞 /
- 猪苓多糖 /
- 解瘀通络肝炎口服液,慢性乙型肝炎
Abstract: To observe the therapeutic effect of chronic hepatitis B with Hepatitis B vaccine, Polyinosinic polycytidylic acid, ZhuLing polysaccharide and Chinese herb Jie Yu TongLuo hepatitis oral liquid.The treated group (48 cases, treated with Hepatitis B vaccine, Polyinosinic polycytidylic acid, ZhuLing polysaccharide, Chinese herb JieYu TongLuo hepatitis oral liquid and common liver protecting medicine) and the control group (30 cases, treated with common liver protecting medicine) were observed for 3 months.The results showed that the rate of turning to negative of HBsAg, HBeAg and HBVDNA in treated group were 8.33%, 75% and 79.2% respectively, and the latter two items had significant difference compared with control group.In treated group the rate of turning to positive of HBsAb and HBeAb were 20.8% and 43.8% respectively.They were different significantly compared with control group.It indicated that combination of Chinese and Western medicine Hepatitis B vaccine, Polyinosinic polycytidylic acid, ZhuLing polysaccharide and JieJu TongLuo hepatitis oral liquid to treat chronic hepatitis B could get satisfying treatment and have little side effect. -
[]〔1〕杨金龙 .猪苓多糖合并乙型肝炎疫苗治疗慢性乙型肝炎〔J〕 .中华消化杂志 , 1995 , 15 (4 ) ∶2 38. []〔2〕巫善明 , 姜嘉 , 徐伟民 , 等 .猪苓多糖注射液合并乙型肝炎疫苗对慢性乙型肝炎的疗效观察〔J〕 .中华传染病杂志 , 1995 , 13 (3) ∶187.
本文二维码
计量
- 文章访问数: 3187
- HTML全文浏览量: 16
- PDF下载量: 941
- 被引次数: 0